🇺🇸 FDA
Patent

US 8901093

Custom vectors for treating and preventing pancreatic cancer

granted A61KA61K2039/53A61K2039/545

Quick answer

US patent 8901093 (Custom vectors for treating and preventing pancreatic cancer) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/53, A61K2039/545, A61K2039/55516, A61K39/0011